Asia Pacific to Provide Potential Opportunities for Cell Line Development in Biotherapeutics North America has acquired the leading position in the worldwide market for biotherapeutics cell line development. In 2014, the opportunity in this region stood at US$23.5 mn, which is likely to increase to US$41 mn by the end of 2022. The presence of a large pool of leading biopharmaceutical companies has stimulated the biotherapeutics cell line development activities in this region, leading to remarkable growth in the market. The increasing base of geriatric population in this region is also presenting huge opportunities for the development of cell lines in biotherapeutics. Europe, which emerged second in this market in 2014, is expected to report steady growth in the near future, thanks to the rising demand for biotherapeutics. The future of cell line development in biotherapeutics, however, lies in Asia Pacific, which stood at third position in 2014. The potential that this region holds can be understood by the fact that Asia Pacific is expected to register the fastest CAGR of 9.40% during the forecast period. The unmet medical needs and the increasing investments by major pharma companies is projected to amplify the development of biotherapeutics cell line in this region. Browse the full Biotherapeutics Cell Line Development Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022 report at http://www.transparencymarketresearch.com/biotherapeutics-cell-line-development-market.html

1. Biotherapeutics Cell Line Development Market
Research Report by Geographical Analysis and Forecast
to 2015 – 2022
Asia Pacific to Provide Potential Opportunities for Cell Line Development in Biotherapeutics
North America has acquired the leading position in the worldwide market for biotherapeutics cell
line development. In 2014, the opportunity in this region stood at US$23.5 mn, which is likely to
increase to US$41 mn by the end of 2022. The presence of a large pool of leading
biopharmaceutical companies has stimulated the biotherapeutics cell line development activities in
this region, leading to remarkable growth in the market. The increasing base of geriatric population
in this region is also presenting huge opportunities for the development of cell lines in
biotherapeutics.
Europe, which emerged second in this market in 2014, is expected to report steady growth in the
near future, thanks to the rising demand for biotherapeutics. The future of cell line development in
biotherapeutics, however, lies in Asia Pacific, which stood at third position in 2014. The potential
that this region holds can be understood by the fact that Asia Pacific is expected to register the
fastest CAGR of 9.40% during the forecast period. The unmet medical needs and the increasing
investments by major pharma companies is projected to amplify the development of biotherapeutics
cell line in this region.
Browse the full Biotherapeutics Cell Line Development Market - Global Industry Analysis,
Size, Share, Growth, Trends, and Forecast 2015 - 2022 report at
http://www.transparencymarketresearch.com/biotherapeutics-cell-line-development-
market.html
Market share analysis for FACS market is also provided in the market overview section of the
report for 2014 in terms of value (%). The report also provides important recommendations for
market players and new entrants. These recommendations would enable existing market players to
expand their market shares and help new companies to establish their presence in the

2. biotherapeutics cell line development market across the world. The report concludes with the
company profiles section, which includes key information about major players in the market such as
financial overview, business strategies, and recent developments. Major players in this market are
Becton Dickinson & Company (U.S.), Beckman Coulter (U.S.), Boehringer Ingelheim Group
(Germany), Catalent Inc. (U.S.), CMC Biologics A/S (Denmark), Lonza Group Ltd. (Switzerland),
EMD Millipore (U.S.), Partec (Sysmex Corporation) (Japan), ProBioGen AG (Germany), Selexis
SA (Germany), Sigma-Aldrich Co. LLC. (U.S.), Sony Biotechnology Inc. (U.S.), and Thermo
Fisher Scientific Inc. (U.S.).
The global biotherapeutics cell line development market has been segmented as follows:
Global Biotherapeutics Cell Line Development Market, by Process
• Transfection & Selection
• Single Cell Cloning
• Manual limited dilution cloning
• FACS
• ClonePix
• Others
Global Biotherapeutics Cell Line Development Market, by CLD Option
• In-house
• Outsource
• Hybrid
• Do-It-Yourself (DIY)
Global Medical Cameras and Microscopes Market, by Geography
• North America
• Europe
• Asia Pacific (APAC)
• Latin America (LATAM)
• Middle East & Africa
Download Sample Copy of Report at :
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8272

3. Browse : Our new press releases
http://www.transparencymarketresearch.com/pressrelease/biotherapeutics-cell-line-
development-market.htm
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business
information reports and services. The company’s exclusive blend of quantitative forecasting and
trend analysis provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use proprietary data sources and various
tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it
always reflects the latest trends and information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact
Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com